News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Licensing HIV Experimental Drugs



8/24/2012 7:09:39 AM

Drugmaker Merck & Co., a pioneer in AIDS research, is licensing two experimental HIV drugs from other companies and advancing one of its own into mid-stage patient testing. Merck, based in Whitehouse Station, Hunterdon County, said Tuesday that it’s signed one deal with Chimerix Inc. for a compound called CMX157, a pill in the HIV drug class called nucleoside reverse transcriptase inhibitors that’s now in early patient testing. Merck will take over development of the drug and get an exclusive worldwide license to market it from Chimerix, based in Research Triangle Park, N.C.



comments powered by Disqus
   
HIV/AIDS

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES